L'absence de comparaison au placebo affaiblit substantiellement la valeur probante de cette observation
Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, Gagnier J, Borenstein M, van der Heijden G, Dahabreh IJ, et al
This new agreement might signal the beginning of the end for compounded GLP-1s, both due to legal pressure from the FDA and GLP-1 makers as well as the steady drop in list prices for authorized products, which are now finally close to the prices for compounded versions
Should a patient stop their long-acting (insulin glargine or detemir) when starting a Glucagon-like peptide-1 (GLP-1) receptor agonist, such as liraglutide?
J Nutr 133:33273330
Sermorelin is a 29-amino-acid natural GHRH fragment that produces physiological, pulsatile GH release with an excellent safety profile ideal for anti-aging and recovery research